Related Experiment Video
Updated: Jan 27, 2026

Author Spotlight: Exploring Heat Shock Proteins in Malaria and Tuberculosis Infections
Published on: March 8, 2024
Heat Shock Protein 70 kDa as a Target for Diagnostics and Therapy of Cardiovascular and Cerebrovascular Diseases
Ekaterina V Konstantinova1, Natalia S Chipigina1, Marina H Shurdumova1
1Pirogov Russian National Research Medical University, Ulitsa Ostrovityanova, 1, Moskva, Russian Federation.
Insights
Heat shock protein 70 (HSP70) increases during ischemia, offering cell protection. Elevated HSP70 in patients suggests its potential for diagnosing and treating cardiovascular and cerebrovascular diseases.
Area of Science:
- Biomedical Science
- Molecular Biology
- Pathophysiology
Background:
- Acute focal ischemia is a key factor in cardiovascular and cerebrovascular diseases like myocardial infarction and stroke.
- Ischemia triggers a significant increase in intracellular heat shock proteins (HSPs), particularly HSP70, across various cell types.
- HSP70 exhibits cytoprotective properties, enhancing cell survival and inhibiting programmed cell death under stress.
Purpose of the Study:
- To review the role of HSP70 in cellular responses to ischemia.
- To explore the diagnostic and therapeutic potential of HSP70 in cardiovascular and cerebrovascular diseases.
Main Methods:
- Literature review of studies on HSP70 expression and function during ischemia.
- Analysis of clinical data showing HSP70 levels in patients with ischemic conditions.
Main Results:
- HSP70 levels rise in cardiomyocytes and brain cells during ischemia, correlating with cardioprotective and neuroprotective effects.
- Elevated HSP70 has been observed in peripheral blood lymphocytes of patients with ischemic stroke and myocardial infarction.
- HSP70 demonstrates significant cytoprotective functions, aiding cell survival and preventing apoptosis.
Conclusions:
- HSP70 plays a crucial role in cellular defense against ischemic injury.
- Elevated HSP70 in peripheral blood may serve as a biomarker for ischemic events.
- HSP70 represents a promising therapeutic target for managing cardiovascular and cerebrovascular diseases.
Abstract:
Acute focal ischemia is a main factor of pathogenesis of a number of widespread cardiovascular and cerebrovascular diseases, in particular, myocardial infarction and ischemic stroke. It is known that under the conditions of ischemia expression of intracellular heat shock proteins (HSPs), especially HSP70, grows greatly irrespective of the cell type. This stress-induced cell response is connected with cytoprotective properties of HSP70. The protective functions of HSP70 contribute to the cell survival under adverse conditions and inhibit development of programmed cell death. It was shown, that the level of HSP70 increases in cardiomyocytes and brain cells in response to ischemia, that was connected with cardioprotective and neuroprotective effects. Besides, in recent years, clinical studies of HSP70 have demonstrated elevated level of HSP70 in peripheral blood lymphocytes in groups of patients with ischemic stroke and myocardial infarction. This review indicates that HSP70 can serve as a target for developing new approaches to diagnostics and therapy of cardiovascular and cerebrovascular diseases.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Responses to Heat and Cold Stress
Gene Therapy
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

